drugset / Trial / NCT01505218

Propofol Patient-controlled Sedation for Endoscopic Retrograde Cholangiopancreatography

NCT01505218 ↗

Completed 281 enrolled University Hospital, Linkoeping
RandomizedParallel-groupOpen-labelTreatment

Summary

Propofol sedation with opioids is used for endoscopic retrograde cholangiopancreatography (ERCP). Combination of sedatives and opioids is associated with increased morbidity/mortality. Delivery of only propofol using a patient-controlled delivery system (patient-controlled sedation, PCS) could be an alternative for this purpose. Comparative studies with PCS for ERCP are few. Therefore, the main objective of this randomized controlled trial was to compare propofol PCS to sedation managed by nurse anaesthetists during ERCP.

Timeline

Start
2010-10
Primary completion
2012-05
Completion
2012-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 5 mg Intravenous

Indications

No indication recorded.